Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
105,274,735
-
Total 13F shares
-
76,543,323
-
Share change
-
-504,454
-
Total reported value
-
$2,666,258,104
-
Put/Call ratio
-
342%
-
Price per share
-
$34.80
-
Number of holders
-
381
-
Value change
-
-$119,524,281
-
Number of buys
-
163
-
Number of sells
-
247
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) as of Q4 2025
As of 31 Dec 2025,
CORCEPT THERAPEUTICS INC - Common Stock, $0.001 par value (CORT) was held by
381 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,543,323 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, DIMENSIONAL FUND ADVISORS LP, and MORGAN STANLEY.
This page lists
381
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.